Hepatotoxicity to sodium valproate: a review.
作者信息
Powell-Jackson P R, Tredger J M, Williams R
出版信息
Gut. 1984 Jun;25(6):673-81. doi: 10.1136/gut.25.6.673.
Abstract
摘要
相似文献
1
Hepatotoxicity to sodium valproate: a review.丙戊酸钠的肝毒性：综述
Gut. 1984 Jun;25(6):673-81. doi: 10.1136/gut.25.6.673.
2
[Reye-like syndrome following valproate therapy in an adult].
Psychiatr Neurol Med Psychol (Leipz). 1988 Jun;40(6):353-7.
3
Valproic acid producing a Reye-like syndrome.
Can J Neurol Sci. 1982 Nov;9(4):435-7. doi: 10.1017/s0317167100044358.
4
Reye-like syndrome associated with valproic acid.与丙戊酸相关的瑞氏综合征样综合征。
Brain Dev. 1983;5(3):334-7. doi: 10.1016/s0387-7604(83)80029-1.
5
Decreased serum carnitine in valproate induced Reye syndrome.丙戊酸盐诱发瑞氏综合征时血清肉碱降低。
Eur J Pediatr. 1982 Nov;139(3):185-6. doi: 10.1007/BF01377353.
6
[An adult case of Reye like syndrome and acute pancreatitis associated with sodium valproate].
Nihon Shokakibyo Gakkai Zasshi. 1992 Jul;89(7):1467-70.
7
[Hepatic toxicity of sodium valproate].[丙戊酸钠的肝毒性]
Arch Fr Pediatr. 1982 Apr;39(4):269.
8
Valproate-induced hepatoxicity: protective effect of L-carnitine supplementation.
Jpn J Psychiatry Neurol. 1990 Jun;44(2):387-8.
9
Valproate hepatotoxicity.丙戊酸盐肝毒性。
Pediatr Neurol. 1985 Sep-Oct;1(5):320. doi: 10.1016/0887-8994(85)90038-4.
10
Valproic-acid-induced thrombocytopenia and hepatotoxicity: discontinuation of treatment?丙戊酸诱导的血小板减少症和肝毒性：停止治疗？
Pharmacology. 2004 Feb;70(2):57-8. doi: 10.1159/000074668.
引用本文的文献
1
Valproate Damaging Effect on Erythrocyte Metabolism as a Decisive Factor in the Development of Encephalopathy.丙戊酸盐对红细胞代谢的损害作用是脑病发生发展的决定性因素。
Biomolecules. 2025 Apr 15;15(4):588. doi: 10.3390/biom15040588.
2
The role of SIRT1-FXR signaling pathway in valproic acid induced liver injury: a quantitative targeted metabolomic evaluation in epileptic children.SIRT1-FXR信号通路在丙戊酸诱导的肝损伤中的作用：癫痫儿童的定量靶向代谢组学评估
Front Pharmacol. 2024 Nov 7;15:1477619. doi: 10.3389/fphar.2024.1477619. eCollection 2024.
3
Discontinuation of Levetiracetam and Valproic Acid Due to Adverse Effects in Early Post-traumatic Seizure Prophylaxis.因早期创伤后癫痫预防中出现不良反应而停用左乙拉西坦和丙戊酸
Cureus. 2023 Oct 26;15(10):e47742. doi: 10.7759/cureus.47742. eCollection 2023 Oct.
4
Black-Box Warnings of Antiseizure Medications: What is Inside the Box?抗癫痫药物的黑框警告：盒子里装的是什么？
Pharmaceut Med. 2023 May;37(3):233-250. doi: 10.1007/s40290-023-00475-x. Epub 2023 Apr 29.
5
Drug Safety in Episodic Migraine Management in Adults. Part 2: Preventive Treatments.成人发作性偏头痛的药物安全性管理。第 2 部分：预防性治疗。
Curr Pain Headache Rep. 2022 Jul;26(7):493-504. doi: 10.1007/s11916-022-01051-9. Epub 2022 May 19.
6
Transcranial photobiomodulation add-on therapy to valproic acid for pentylenetetrazole-induced seizures in peripubertal rats.经颅光生物调节辅助丙戊酸治疗青春期前戊四氮致痫大鼠的发作。
BMC Complement Med Ther. 2022 Mar 21;22(1):81. doi: 10.1186/s12906-022-03562-9.
7
Idiosyncratic Valproic Acid-Induced Hepatotoxicity in a Sickle Cell Patient.一名镰状细胞病患者发生的丙戊酸特异质性肝毒性
J Pharm Technol. 2015 Feb;31(1):43-46. doi: 10.1177/8755122514550490. Epub 2014 Sep 11.
8
Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target?表观遗传学在肝纤维化中的作用：组蛋白去乙酰化酶（HDACs）能否成为治疗靶点？
Cells. 2020 Oct 19;9(10):2321. doi: 10.3390/cells9102321.
9
Valproate-induced Drug Rash Eosinophilia with Systemic Symptoms Syndrome: An Unknown Hepatotoxicity.丙戊酸盐诱导的伴有全身症状综合征的药物疹嗜酸性粒细胞增多症：一种未知的肝毒性
Euroasian J Hepatogastroenterol. 2019 Jul-Dec;9(2):102-103. doi: 10.5005/jp-journals-10018-1298.
10
An Epileptic Patient with Recurrent Hyperbilirubinemia Caused by Gilbert Syndrome.一名患有吉尔伯特综合征所致复发性高胆红素血症的癫痫患者。
Case Rep Gastroenterol. 2020 Jan 22;14(1):39-47. doi: 10.1159/000504645. eCollection 2020 Jan-Apr.
本文引用的文献
1
Bile acid metabolism in cirrhosis. VIII. Quantitative evaluation of bile acid synthesis from [7 beta-3H]7 alpha-hydroxycholesterol and [G-3H]26-hydroxycholesterol.肝硬化中的胆汁酸代谢。VIII. 从[7β-³H]7α-羟基胆固醇和[G-³H]26-羟基胆固醇合成胆汁酸的定量评估。
Hepatology. 1982 Jan-Feb;2(1):59-66. doi: 10.1002/hep.1840020110.
2
Treatment of childhood epilepsy with valproic acid: results of the first 100 patients in a 6-month trial.丙戊酸治疗儿童癫痫：6个月试验中首批100例患者的结果。
Neurology. 1980 Jan;30(1):31-5. doi: 10.1212/wnl.30.1.31.
3
Sodium valproate: pharmacokinetics and effectivensss in treating intractable seizures.丙戊酸钠：治疗难治性癫痫的药代动力学及有效性
Neurology. 1980 Jan;30(1):1-6. doi: 10.1212/wnl.30.1.1.
4
[Laboratory parameters in valproate therapy].
Nervenarzt. 1982 Dec;53(12):684-90.
5
Valproic acid producing a Reye-like syndrome.
Can J Neurol Sci. 1982 Nov;9(4):435-7. doi: 10.1017/s0317167100044358.
6
Valproate-induced hepatic steatogenesis in rats.丙戊酸盐诱导大鼠肝脏脂肪生成
Hepatology. 1982 Nov-Dec;2(6):870-3. doi: 10.1002/hep.1840020622.
7
Sodium valproate in the induction of unusual hepatotoxicity.丙戊酸钠诱发罕见肝毒性
Hepatology. 1982 Sep-Oct;2(5):648-9. doi: 10.1002/hep.1840020520.
8
Asymptomatic hyperammonemia in patients receiving valproic acid.接受丙戊酸治疗的患者出现无症状性高氨血症。
Arch Neurol. 1982 Sep;39(9):591-2. doi: 10.1001/archneur.1982.00510210061016.
9
10
Valproate and clonazepam in the treatment of severe progressive myoclonus epilepsy.丙戊酸盐与氯硝西泮治疗严重进行性肌阵挛癫痫
Arch Neurol. 1982 Apr;39(4):236-8. doi: 10.1001/archneur.1982.00510160042008.
Zotero 插件